Omar Khwaja - 21 May 2021 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
Chief Medical Officer and Head of Research & Development.
Signature
/s/ Allison Dorval, as Attorney-in-Fact for Omar Khwaja
Issuer symbol
VYGR
Transactions as of
21 May 2021
Net transactions value
-$14,169
Form type
4
Filing time
25 May 2021, 16:31:13 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Sale $14,169 -3,516 -2.8% $4.03 120,509 21 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on May 20, 2021. The reporting person structured the durable automatic sales instructions to constitute a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person.

Remarks:

Chief Medical Officer and Head of Research & Development.